Chitosan in Cryptococcus

隐球菌中的壳聚糖

• 批准号: 8761728
• 负责人: Jennifer K. Lodge
• 金额: $ 43.06万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-12-15 至 2019-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8761728
• 关键词: Acquired Immunodeficiency Syndrome; Address; Adverse effects; Anabolism; Animal Model; Antibodies; Antifungal Agents; Antifungal Therapy; Binding; Biochemical; Biological Models; Cell Wall; Cells; Cessation of life; Chitin; Chitin Synthase; Chitosan; Complex; Country; Cryptococcus; Cryptococcus neoformans; Cryptococcus neoformans infection; Data; Development; Disease; Disease Progression; Drug Targeting; Enzyme Interaction; Enzymes; Funding; Fungal Components; Genetic; Goals; Grant; Growth; Human; Immune; Immune response; Immunocompromised Host; Individual; Integral Membrane Protein; Melanins; Membrane; Modeling; Mouse Strains; Mutate; Mycoses; New Agents; Organ Transplantation; Organelles; Organism; Pathogenesis; Polysaccharides; Production; Proteins; Relapse; Risk; Role; Solid; Specificity; System; Testing; Toxic effect; Virulence; Virulence Factors; Work; capsule; chemotherapy; complement C3 precursor; design; drug development; fungus; inhibitor/antagonist; killings; macrophage; mouse model; mutant; patient population; prevent; promoter; public health relevance; response; tool

DESCRIPTION (provided by applicant): Cryptococcus neoformans is a pathogenic fungus that is found world-wide and causes meningioencephalitis, particularly in immunocompromised individuals. It is invariably fatal unless treated, and the current antifungals are inadequate to effectively cure this disease, due to inherent toxicities or the inability to kill the fungus and prevent relapse. Recent studies have indicated that there are over 1,000,000 new cases of cryptococcosis in the world each year, which results in over 600,000 deaths. New agents to treat Cryptococcus are needed, and the fungal cell wall is an attractive target, since it is unique to fungi and absent in humans. We have shown that chitosan, the deacetylated form of chitin, is a critical component of the Cryptococcal cell wall and is absolutely required for virulence using a mouse model of cryptococcosis. It is also necessary for persistence in the mouse - strains lacking chitosan were cleared within 48 hrs, much more rapidly than other major virulence factors. Our studies have further identified the key enzymes required for chitosan production in this fungus. Because Cryptococcus is a manipulable organism, with a robust genetic system and solid animal models, it is an excellent model system to study chitosan biosynthesis and the role of chitosan in disease progression. In this renewal application, we propose to extend our studies on chitosan biosynthesis and chitosan's role in pathogenesis, with the long-term goal of delineating the necessary components and their interactions for chitosan biosynthesis. In three specific aims, we will address the following questions: Aim 1. How is specificity achieved to deacetylate the chitin produced by the single chitin synthase (out of eight) and the single chitin synthase regulator (out of three)? Aim 2. Which proteins are necessary for chitosan production, and how do they interact? We have already identified some of the proteins, and will test whether any of them are limiting, and whether they are co-localized and form complexes. We will also explore whether there are additional proteins that are necessary for chitosan production. Aim 3. Why are chitosan deficient mutants cleared so quickly? Is the host response to the chitosan deficient mutants different than the host response to wild type Cryptococcus and/or are the chitosan deficient cells more susceptible to killing by the host?

描述（由申请人提供）：新型隐球菌是一种世界范围内发现的致病性真菌，可引起脑膜脑炎，特别是在免疫功能低下的个体中。除非治疗，否则它总是致命的，由于固有的毒性或无法杀死真菌并防止复发，目前的抗真菌药物不足以有效治愈这种疾病。最近的研究表明，世界上每年有100多万新发隐球菌病病例，其中60多万人死亡。需要新的药物来治疗隐球菌，真菌细胞壁是一个有吸引力的目标，因为它是独特的